220 related articles for article (PubMed ID: 17306334)
1. Loss of claudins-1 and -7 and expression of claudins-3 and -4 correlate with prognostic variables in prostatic adenocarcinomas.
Sheehan GM; Kallakury BV; Sheehan CE; Fisher HA; Kaufman RP; Ross JS
Hum Pathol; 2007 Apr; 38(4):564-9. PubMed ID: 17306334
[TBL] [Abstract][Full Text] [Related]
2. Smad4 protein expression correlates with grade, stage, and DNA ploidy in prostatic adenocarcinomas.
Sheehan GM; Kallakury BV; Sheehan CE; Fisher HA; Kaufman RP; Ross JS
Hum Pathol; 2005 Nov; 36(11):1204-9. PubMed ID: 16260274
[TBL] [Abstract][Full Text] [Related]
3. Low claudin expression is associated with high Gleason grade in prostate adenocarcinoma.
Väre P; Loikkanen I; Hirvikoski P; Vaarala MH; Soini Y
Oncol Rep; 2008 Jan; 19(1):25-31. PubMed ID: 18097572
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of matrix metalloproteinase 2 and tissue inhibitor of metalloproteinase 2 expression in prostate cancer.
Ross JS; Kaur P; Sheehan CE; Fisher HA; Kaufman RA; Kallakury BV
Mod Pathol; 2003 Mar; 16(3):198-205. PubMed ID: 12640098
[TBL] [Abstract][Full Text] [Related]
5. Claudin expression in gastric adenocarcinomas: a tissue microarray study with prognostic correlation.
Resnick MB; Gavilanez M; Newton E; Konkin T; Bhattacharya B; Britt DE; Sabo E; Moss SF
Hum Pathol; 2005 Aug; 36(8):886-92. PubMed ID: 16112005
[TBL] [Abstract][Full Text] [Related]
6. Expression pattern and prognostic significance of claudins 1, 4, and 7 in nasopharyngeal carcinoma.
Hsueh C; Chang YS; Tseng NM; Liao CT; Hsueh S; Chang JH; Wu IC; Chang KP
Hum Pathol; 2010 Jul; 41(7):944-50. PubMed ID: 20334898
[TBL] [Abstract][Full Text] [Related]
7. beta-catenin expression and claudin expression pattern as prognostic factors of prostatic cancer progression.
Szász AM; Nyirády P; Majoros A; Szendrõi A; Szûcs M; Székely E; Tõkés AM; Romics I; Kulka J
BJU Int; 2010 Mar; 105(5):716-22. PubMed ID: 19818082
[TBL] [Abstract][Full Text] [Related]
8. Claudin upregulation in ovarian carcinoma effusions is associated with poor survival.
Kleinberg L; Holth A; Trope CG; Reich R; Davidson B
Hum Pathol; 2008 May; 39(5):747-57. PubMed ID: 18439941
[TBL] [Abstract][Full Text] [Related]
9. Claudin 1 differentiates endometrioid and serous papillary endometrial adenocarcinoma.
Sobel G; Németh J; Kiss A; Lotz G; Szabó I; Udvarhelyi N; Schaff Z; Páska C
Gynecol Oncol; 2006 Nov; 103(2):591-8. PubMed ID: 16797678
[TBL] [Abstract][Full Text] [Related]
10. Distinct claudin expression profile in histologic subtypes of lung cancer.
Moldvay J; Jäckel M; Páska C; Soltész I; Schaff Z; Kiss A
Lung Cancer; 2007 Aug; 57(2):159-67. PubMed ID: 17418912
[TBL] [Abstract][Full Text] [Related]
11. Reduced expression of the claudin-7 gene correlates with venous invasion and liver metastasis in colorectal cancer.
Oshima T; Kunisaki C; Yoshihara K; Yamada R; Yamamoto N; Sato T; Makino H; Yamagishi S; Nagano Y; Fujii S; Shiozawa M; Akaike M; Wada N; Rino Y; Masuda M; Tanaka K; Imada T
Oncol Rep; 2008 Apr; 19(4):953-9. PubMed ID: 18357381
[TBL] [Abstract][Full Text] [Related]
12. Claudin expression in rectal well-differentiated endocrine neoplasms (carcinoid tumors).
Ishida M; Kushima R; Okabe H
Oncol Rep; 2009 Jan; 21(1):113-7. PubMed ID: 19082451
[TBL] [Abstract][Full Text] [Related]
13. Loss of the tight junction protein claudin 4 correlates with histological growth-pattern and differentiation in advanced gastric adenocarcinoma.
Lee SK; Moon J; Park SW; Song SY; Chung JB; Kang JK
Oncol Rep; 2005 Feb; 13(2):193-9. PubMed ID: 15643498
[TBL] [Abstract][Full Text] [Related]
14. Expression of occludin and claudins 1, 3, 4, and 7 in urothelial carcinoma of the upper urinary tract.
Nakanishi K; Ogata S; Hiroi S; Tominaga S; Aida S; Kawai T
Am J Clin Pathol; 2008 Jul; 130(1):43-9. PubMed ID: 18550469
[TBL] [Abstract][Full Text] [Related]
15. Claudin-1 protein expression is a prognostic marker of patient survival in renal cell carcinomas.
Fritzsche FR; Oelrich B; Johannsen M; Kristiansen I; Moch H; Jung K; Kristiansen G
Clin Cancer Res; 2008 Nov; 14(21):7035-42. PubMed ID: 18981000
[TBL] [Abstract][Full Text] [Related]
16. Claudins 1, 3, 4, 5 and 7 in esophageal cancer: loss of claudin 3 and 4 expression is associated with metastatic behavior.
Takala H; Saarnio J; Wiik H; Soini Y
APMIS; 2007 Jul; 115(7):838-47. PubMed ID: 17614851
[TBL] [Abstract][Full Text] [Related]
17. Claudin expression is dysregulated in prostate adenocarcinomas but does not correlate with main clinicopathological parameters.
Coutinho-Camillo CM; Lourenço SV; da Fonseca FP; Soares FA
Pathology; 2011 Feb; 43(2):143-8. PubMed ID: 21233676
[TBL] [Abstract][Full Text] [Related]
18. Claudins 1, 4, 5, 7 and occludin in ameloblastomas and developing human teeth.
Bello IO; Soini Y; Slootweg PJ; Salo T
J Oral Pathol Med; 2007 Jan; 36(1):48-54. PubMed ID: 17181742
[TBL] [Abstract][Full Text] [Related]
19. Expression pattern of claudins 5 and 7 distinguishes solid-pseudopapillary from pancreatoblastoma, acinar cell and endocrine tumors of the pancreas.
Comper F; Antonello D; Beghelli S; Gobbo S; Montagna L; Pederzoli P; Chilosi M; Scarpa A
Am J Surg Pathol; 2009 May; 33(5):768-74. PubMed ID: 19194274
[TBL] [Abstract][Full Text] [Related]
20. The diagnostic role of claudins in serous effusions.
Kleinberg L; Holth A; Fridman E; Schwartz I; Shih IeM; Davidson B
Am J Clin Pathol; 2007 Jun; 127(6):928-37. PubMed ID: 17509990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
